SCHEMBL30892113

SCHEMBL30892113

O=C1CCC(N2C(=O)c3cnc(N4CCNCC4)nc3C2=O)C(=O)N1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.50
▸ DDB1 Q16531 12/20 0.50
▸ IKZF3 Q9UKT9 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ OPRM1 P35372 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ TNF P01375 1/20 0.43
▸ IL1B P01584 1/20 0.43
▸ TBXA2R P21731 1/20 0.43
▸ IKZF1 Q13422 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20231888 1.00 CRBN (0.50) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22297288 0.88 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22006092 0.83 CYP1A2 (0.41) ALDH1A1CYP1A2TSHR
SCHEMBL27099145 0.81 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL30892104 0.80 CRBN (0.56) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL21464174 0.80 CRBN (0.56) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20234574 0.80 CRBN (0.56) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20234994 0.80 CRBN (0.47) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20231784 0.80 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL30892119 0.80 CRBN (0.57) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118480030-A Cerebulin ligands and bifunctional compounds comprising same 阿尔维纳斯运营股份有限公司 2024-08-13 — — CN disclosed
CN-112262134-B Cerebulin ligands and bifunctional compounds comprising same 阿尔维纳斯运营股份有限公司 2024-05-24 — — CN disclosed
Send feedback